3661
Female Health Conditions and Hair Loss: What Iron Deficiency and PCOS Can Tell Us About Your Hair
작성일
2026-06-17
조회수
6
Hair loss is often thought of as a problem caused solely by genetics. However, in women, underlying health conditions can significantly influence hair growth, hair thickness, and the rate of hair shedding.
Two of the most commonly discussed conditions are iron deficiency (low ferritin levels) and polycystic ovary syndrome (PCOS). While neither condition automatically causes hair loss in every patient, both can create an environment that makes healthy hair growth more difficult.
Understanding these factors can help identify whether hair loss is simply part of a genetic pattern or a sign that the body needs additional attention.
Iron functions much like a reserve energy supply for the body. Ferritin, a protein that stores iron, acts as the body's iron bank account. When ferritin levels become depleted, tissues with high cellular turnover—such as hair follicles—may be affected first.
Research has shown that in patients with established androgenetic alopecia, ferritin levels alone are not always significantly different from those in people without hair loss. This suggests that iron deficiency is not necessarily the primary cause of genetic hair loss.
However, the story may be different in the early stages of hair thinning.
Recent studies suggest that among individuals with early androgenetic alopecia, higher iron levels within hair follicles were associated with thicker hair shafts. In other words, iron may not prevent genetic hair loss entirely, but it may help maintain hair quality and diameter during the early stages of miniaturization.
For women experiencing:
checking ferritin levels through a blood test may be worthwhile.
PCOS is one of the most common endocrine disorders affecting women of reproductive age.
Many women associate PCOS-related hair loss with elevated androgen (male hormone) levels. While hormones certainly play a role, recent research suggests that the relationship is more complex.
One study found that more than 80% of women with PCOS also showed signs of female pattern hair loss. Interestingly, blood androgen levels alone were not strong predictors of hair loss severity.
Instead, other factors appeared to be more closely associated with hair loss progression, including:
These findings suggest that hair follicles may be influenced not only by hormones but also by the overall metabolic health of the body.
Hair follicles are among the most metabolically active structures in the body. They require a constant supply of nutrients, oxygen, and energy to maintain normal growth cycles.
In women with PCOS, metabolic disturbances can create a less favorable environment for hair follicles.
Research has shown that:
This does not mean that every woman with PCOS will develop hair loss. However, it highlights the importance of looking beyond hormone levels alone when evaluating hair thinning.
The answer depends on the underlying cause.
If hair thinning is primarily related to iron deficiency, restoring iron stores may help improve hair quality and support healthier growth over time. Because hair grows slowly, noticeable improvements often require several months of consistent management.
For women with PCOS, treatment is usually more complex. Managing hormone balance, metabolic health, sleep quality, and lifestyle factors may help slow progression and improve the scalp environment.
However, if female pattern hair loss or androgenetic alopecia has already developed, medical treatments specifically targeting hair loss are often necessary in addition to addressing the underlying condition.
Women experiencing any of the following symptoms may benefit from a comprehensive hair loss evaluation:
Hair loss is often multifactorial. Identifying both the internal health factors and the genetic factors involved can lead to more effective long-term treatment planning.
Iron deficiency and PCOS are not always the direct causes of hair loss, but they can significantly influence the environment in which hair follicles function.
Iron appears to play an important role in maintaining hair shaft thickness during the early stages of hair loss, while PCOS-related hair loss is increasingly linked to broader metabolic health factors rather than hormones alone.
For women experiencing thinning hair, looking beyond the scalp and evaluating overall health may provide important clues that support better treatment outcomes.
References
1. Blume-Peytavi U. Androgenetic Alopecia. In: Fitzpatrick's Dermatology. 9th ed. McGraw-Hill Education; 2019.
2. Debinta AA, Budianti WK, Hardjodipuro A, et al. Serum ferritin and hair iron content in correlation to hair diameter and density: a case-control study. Dermatology Reports. 2026.
3. Zhang D, LaSenna C, Shields BE. Serum Ferritin Levels: A Clinical Guide in Patients With Hair Loss. Cutis. 2023;112(2):62-67.
4. Kaiser MR, Grimm A, Tosti A. Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs. Clinical, Cosmetic and Investigational Dermatology. 2023;16:1047-1067.
5. Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. Journal of the American Academy of Dermatology. 2006;54(5):824-844.
6. Gonul M, Cakmak SK, Soylu S, et al. Serum vitamin B12, folate, ferritin, and iron levels in patients with alopecia areata. Indian Journal of Dermatology, Venereology and Leprology. 2009;75(5):552.
7. Hasan F, Ahmed N, Malik T, et al. Frequency of androgenetic alopecia in patients presenting with polycystic ovarian syndrome at tertiary care hospital Karachi. Journal of Pakistan Association of Dermatologists. 2026.
8. Starace M, Orlando G, Alessandrini A, Piraccini BM. Female androgenetic alopecia: an update. American Journal of Clinical Dermatology. 2020;21(1):69-84.
9. Bienenfeld A, Azarchi S, Lo Sicco K, et al. Androgens in women. Journal of the American Academy of Dermatology. 2019;80(6):1497-1506.
10. Qiu Y, Yin C, Huang Y, et al. Association of androgenetic alopecia with metabolic syndrome: a systematic review and meta-analysis. Acta Dermato-Venereologica. 2022;102(4).